Therapies for HIV with RNAi

Current Opinion in Molecular Therapeutics

Volumn 8, Issue 1, 2006, Pages 52-61

  Nekhai, Sergie ^a   Jerebtova, Marina ^b  

^a HOWARD UNIVERSITY   (United States)

^b CHILDREN S RESEARCH INSTITUTE   (United States)

Author keywords

Dicer inhibition; HIV 1; Interference; RNA; siRNA delivery; Viral escape

Indexed keywords

4 AMINOBUTYRIC ACID B RECEPTOR; CD47 ANTIGEN; CD68 ANTIGEN; CHEMOKINE RECEPTOR CCR4; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CCR7; CHEMOKINE RECEPTOR CXCR4; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 9; CYCLIN T1; CYCLOPHILIN A; DEOXYHYPUSINE SYNTHASE; GAG PROTEIN; GLYCOPROTEIN GP 120; GLYCOPROTEIN GP 41; GLYCOPROTEIN P 15095; HERMES ANTIGEN; LENTIVIRUS VECTOR; MESSENGER RNA; NEF PROTEIN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; POL PROTEIN; PROTEIN SAM68; REV PROTEIN; SHORT HAIRPIN RNA; SMALL INTERFERING RNA; TRANSACTIVATOR PROTEIN; TUMOR NECROSIS FACTOR RECEPTOR 2; UNINDEXED DRUG; VIF PROTEIN; VPU PROTEIN;

ANTIVIRAL ACTIVITY; CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; DRUG TARGETING; ENZYME INHIBITION; GENE EXPRESSION; GENE SILENCING; GENE TRANSFER; GENETIC TRANSDUCTION; GENETIC TRANSFECTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; NONVIRAL GENE THERAPY; REVIEW; RNA DEGRADATION; RNA INTERFERENCE; RNA VECTOR; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY; VIRUS INHIBITION; VIRUS REPLICATION; VIRUS TRANSCRIPTION; VIRUS TRANSMISSION;

ANIMALS; GENES, VIRAL; HIV INFECTIONS; HIV-1; HUMANS; RNA INTERFERENCE; RNA, SMALL INTERFERING; SUBSTRATE SPECIFICITY;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; LENTIVIRUS; MAMMALIA;

EID: 32544441871     PISSN: 14648431     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (69)

1. Dorsett Y, Tuschl T: siRNAs: Applications in functional genomics and potential as therapeutics. Nat Rev Drug Discov (2004) 3(4):318-329.
2. Tang G: siRNA and miRNA: An insight into RISCs. Trends Biochem Sci (2005) 30(2):106-114.
3. Chendrimada TP, Gregory RI, Kumaraswamy E, Norman J, Cooch N, Nishikura K, Shiekhattar R: TRBP recruits the Dicer complex to Ago2 for microRNA processing and gene silencing. Nature (2005) 436(7051):740-744.
4. Haase AD, Jaskiewicz L, Zhang H, Laine S, Sack R, Gatignol A, Filipowicz W: TRBP, a regulator of cellular PKR and HIV-1 virus expression, interacts with Dicer and functions in RNA silencing. EMBO Rep (2005) 6(10):961-967.
5. Gatignol A, Buckler-White A, Berkhout B, Jeang KT: Characterization of a human TAR RNA-binding protein that activates the HIV-1 LTR. Science (1991) 251(5001):1597-1600.
6. Gatignol A, Laine S, Clerzius G: Dual role of TRBP in HIV replication and RNA interference: Viral diversion of a cellular pathway or evasion from antiviral immunity? Retrovirology (2005) 2:65.
7. Williams BR: PKR; a sentinel kinase for cellular stress. Oncogene (1999) 18(45):6112-6120.
8. Ong CL, Thorpe JC, Gorry PR, Bannwarth S, Jaworowski A, Howard JL, Chung S, Campbell S, Christensen HS, Clerzius G, Mouland AJ et al: Low TRBP levels support an innate human immunodeficiency virus type 1 resistance in astrocytes by enhancing the PKR antiviral response. J Virol (2005) 79(20):12763-12772.
9. Nekhai S, Kumar A, Bottaro DP, Petryshyn R: Peptides derived from the interferon-induced PKR prevent activation by HIV-1 TAR RNA. Virology (1996) 222(1):193-200.
10. Gregory RI, Chendrimada TP, Cooch N, Shiekhattar R: Human RISC couples microRNA biogenesis and posttranscriptional gene silencing. Cell (2005) 123(4):631-640.
11. Lee MT, Coburn GA, McClure MO, Cullen BR: Inhibition of human immunodeficiency virus type 1 replication in primary macrophages by using Tat- or CCR5-specific small interfering RNAs expressed from a lentivirus vector. J Virol (2003) 77(22):11964-11972.
12. Coburn GA, Cullen BR: Potent and specific inhibition of human immunodeficiency virus type 1 replication by RNA interference. J Virol (2002) 76(18):9225-9231.
13. Park WS, Hayafune M, Miyano-Kurosaki N, Takaku H: Specific HIV-1 env gene silencing by small interfering RNAs in human peripheral blood mononuclear cells. Gene Ther (2003) 10(24):2046-2050.
14. Jacque JM, Triques K, Stevenson M: Modulation of HIV-1 replication by RNA interference. Nature (2002) 418(6896):435-438.
15. Barnor JS, Miyano-Kurosaki N, Yamaguchi K, Abumi Y, Ishikawa K, Yamamoto N: Lentiviral-mediated delivery of combined HIV-1 decoy TAR and Vif siRNA as a single RNA molecule that cleaves to inhibit HIV-1 in transduced cells. Nucleosides Nucleotides Nucleic Acids (2005) 24(5-7):431-434.
16. Bennasser Y, Le SY, Benkirane M, Jeang KT: Evidence that HIV-1 encodes an siRNA and a suppressor of RNA silencing. Immunity (2005) 22(5):607-619.
17. Arrighi JF, Pion M, Wiznerowicz M, Geijtenbeek TB, Garcia E, Abraham S, Leuba F, Dutoit V, Ducrey-Rundquist O, van Kooyk Y, Trono D et al: Lentivirus-mediated RNA interference of DC-SIGN expression inhibits human immunodeficiency virus transmission from dendritic cells to T cells. J Virol (2004) 78(20):10848-10855.
18. Anderson J, Akkina R: HIV-1 resistance conferred by siRNA cosuppression of CXCR4 and CCR5 coreceptors by a bispecific lentiviral vector. AIDS Res Ther (2005) 2(1):1.
19. Dunn SJ, Khan IH, Chan UA, Scearce RL, Melara CL, Paul AM, Sharma V, Bih FY, Holzmayer TA, Luciw PA, Abo A: Identification of cell surface targets for HIV-1 therapeutics using genetic screens. Virology (2004) 321(2):260-273.
20. Neil SJ, Aasa-Chapman MM, Clapham PR, Nibbs RJ, McKnight A, Weiss RA: The promiscuous CC chemokine receptor D6 is a functional coreceptor for primary isolates of human immunodeficiency virus type 1 (HIV-1) and HIV-2 on astrocytes. J Virol (2005) 79(15):9618-9624.
21. Liu S, Asparuhova M, Brondani V, Ziekau I, Klimkait T, Schumperli D: Inhibition of HIV-1 multiplication by antisense U7 snRNAs and siRNAs targeting cyclophilin A. Nucleic Acids Res (2004) 32(12):3752-3759.
22. Ye Y, De Leon J, Yokoyama N, Naidu Y, Camerini D: DBR1 siRNA inhibition of HIV-1 replication. Retrovirology (2005) 2:63.
23. Kameoka M, Nukuzuma S, Itaya A, Tanaka Y, Ota K, Ikuta K, Yoshihara K: RNA interference directed against Poly(ADP-ribose) polymerase 1 efficiently suppresses human immunodeficiency virus type 1 replication in human cells. J Virol (2004) 78(16):8931-8934.
24. Brady J, Kashanchi F: Tat gets the "green" light on transcription initiation. Retrovirology (2005) 2:69.
25. Chiu YL, Cao H, Jacque JM, Stevenson M, Rana TM: Inhibition of human immunodeficiency virus type 1 replication by RNA interference directed against human transcription elongation factor P-TEFb (CDK9/CyclinT1). J Virol (2004) 78(5):2517-2529.
26. Liang WS, Maddukuri A, Teslovich TM, de la Fuente C, Agbottah E, Dadgar S, Kehn K, Hautaniemi S, Pumfery A, Stephan DA, Kashanchi F: Therapeutic targets for HIV-1 infection in the host proteome. Retrovirology (2005) 2(1):20.
27. Li Z, Xiong Y, Peng Y, Pan J, Chen Y, Wu X, Hussain S, Tien P, Guo D: Specific inhibition of HIV-1 replication bY short hairpin RNAs targeting human cyclin T1 without inducing apoptosis. FEBS Lett (2005) 579(14):3100-3106.
28. Ping YH, Chu CY, Cao H, Jacque JM, Stevenson M, Rana TM: Modulating HIV-1 replication by RNA interference directed against human transcription elongation factor SPT5. Retrovirology (2004) 1(1):46.
29. Nguyen VT, Kiss T, Michels AA, Bensaude O: 7SK small nuclear RNA binds to and inhibits the activity of CDK9/cyclin T complexes. Nature (2001) 414(6861):322-325.
30. Yang Z, Zhu Q, Luo K, Zhou Q: The 7SK small nuclear RNA inhibits the CDK9/cyclin T1 kinase to control transcription. Nature (2001) 414(6861):317-322.
31. Haaland RE, Herrmann CH, Rice AP: siRNA depletion of 7SK snRNA induces apoptosis but does not affect expression of the HIV-1 LTR or P-TEFb-dependent cellular genes. J Cell Physiol (2005) 205(3):463-470.
32. Kaldis P, Aleem E: Cell cycle sibling rivalry: Cdc2 vs. Cdk2. Cell Cycle (2005) 4(11):1491-1494.
33. Deng L, Ammosova T, Pumfery A, Kashanchi F, Nekhai S: HIV-1 Tat interaction with RNA polymerase II C-terminal domain (CTD) and a dynamic association with CDK2 induce CTD phosphorylation and transcription from HIV-1 promoter. J Biol Chem (2002) 277(37):33922-33929.
34. Agbottah E, de La Fuente C, Nekhai S, Barnett A, Gianella-Borradori A, Pumfery A, Kashanchi F: Antiviral activity of CYC202 in HIV-1-infected cells. J Biol Chem (2005) 280(4):3029-3042.
35. Ammosova T, Berro R, Kashanchi F, Nekhai S: RNA interference directed to Cdk2 inhibits HIV-1 transcription. Virology (2005) 341(2):171-178.
36. Hauber I, Bevec D, Heukeshoven J, Kratzer F, Horn F, Choidas A, Harrer T, Hauber J: Identification of cellular deoxyhypusine synthase as a novel target for antiretroviral therapy. J Clin Invest (2005) 115(1):76-85.
37. Yu Z, Sanchez-Velar N, Catrina IE, Kittler EL, Udofia EB, Zapp ML: The cellular HIV-1 Rev cofactor hRIP is required for viral replication. Proc Natl Acad Sci USA (2005) 102(11):4027-4032.
38. Modem S, Badri KR, Holland TC, Reddy TR: Sam68 is absolutely required for Rev function and HIV-1 production. Nucleic Acids Res (2005) 33(3):873-879.
39. Kremer M, Schnierle BS: HIV-1 Vif: HIV's weapon against the cellular defense factor APOBEC3G. Curr HIV Res (2005) 3(4):339-344.
40. Liu B, Sarkis PT, Luo K, Yu Y, Yu XF: Regulation of Apobec3F and human immunodeficiency virus type 1 Vif by Vif-Cul5-ElonB/C E3 ubiquitin ligase. J Virol (2005) 79(15):9579-9587.
41. Ward DM, Vaughn MB, Shiflett SL, White PL, Pollock AL, Hill J, Schnegelberger R, Sundquist WI, Kaplan J: The role of LIP5 and CHMP5 in multivesicular body formation and HIV-1 budding in mammalian cells. J Biol Chem (2005) 280(11):10548-10555.
42. Allen TM, Cullis PR: Drug delivery systems: Entering the mainstream. Science (2004) 303(5665):1818-1822.
43. Takeshita F, Minakuchi Y, Nagahara S, Honma K, Sasaki H, Hirai K, Teratani T, Namatame N, Yamamoto Y, Hanai K, Kato T et al: Efficient delivery of small interfering RNA to bone-metastatic tumors by using atelocollagen in vivo. Proc Natl Acad Sci USA (2005) 102(34):12177-12182.
44. Soutschek J, Akinc A, Bramlage B, Charisse K, Constien R, Donoghue M, Elbashir S, Geick A, Hadwiger P, Harborth J, John M et al: Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs. Nature (2004) 432(7014):173-178.
45. Overhoff M, Sczakiel G: Phosphorothioate-stimulated uptake of short interfering RNA by human cells. EMBO Rep (2005) 6(12):1176-1181.
46. Inoue A, Takahashi KA, Mazda O, Terauchi R, Arai Y, Kishida T, Shin-Ya M, Asada H, Morihara T, Tonomura H, Ohashi S et al: Electrotransfer of small interfering RNA ameliorated arthritis in rats. Biochem Biophys Res Commun (2005) 336(3):903-908.
47. Song E, Zhu P, Lee SK, Chowdhury D, Kussman S, Dykxhoorn DM, Feng Y, Palliser D, Weiner DB, Shankar P, Marasco WA, Lieberman J: Antibody mediated in vivo delivery of small interfering RNAs via cell-surface receptors. Nat Biotechnol (2005) 23(6):709-717.
48. Williams BR: Targeting specific cell types with silencing RNA. N Engl J Med (2005) 353(13):1410-1411.
49. Park J, Nadeau P, Zucali JR, Johnson CM, Mergia A: Inhibition of simian immunodeficiency virus by foamy virus vectors expressing siRNAs. Virology (2005) 343(2):275-282.
50. Poluri A, van Maanen M, Sutton RE: Genetic therapy for HIV/AIDS. Expert Opin Biol Ther (2003) 3(6):951-963.
51. Chang LJ, Liu X, He J: Lentiviral siRNAs targeting multiple highly conserved RNA sequences of human immunodeficiency virus type 1. Gene Ther (2005) 12(14):1133-1144.
52. Lee SK, Dykxhoorn DM, Kumar P, Ranjbar S, Song E, Maliszewski LE, Francois-Bongarcon V, Goldfeld A, Swamy NM, Lieberman J, Shankar P: Lentiviral delivery of short hairpin RNAs protects CD4 T cells from multiple clades and primary isolates of HIV. Blood (2005) 106(3):818-826.
53. Muhlebach MD, Wolfrum N, Schule S, Tschulena U, Sanzenbacher R, Flory E, Cichutek K, Schweizer M: Stable transduction of primary human monocytes by simian lentiviral vector PBJ. Mol Ther (2005) 12(6):1206-1216.
54. Li MJ, Kim J, Li S, Zaia J, Yee JK, Anderson J, Akkina R, Rossi JJ: Long-term inhibition of HIV-1 infection in primary hematopoietic cells by lentiviral vector delivery of a triple combination of anti-HIV shRNA, anti-CCR5 ribozyme, and a nucleolar-localizing TAR decoy. Mol Ther (2005) 12(5):900-909.
55. Braun SE, Wong FE, Connole M, Qiu G, Lee L, Gillis J, Lu X, Humeau L, Slepushkin V, Binder GK, Dropulic B, Johnson RP: Inhibition of simian/human immunodeficiency virus replication in CD4+ T cells derived from lentiviral-transduced CD34+ hematopoietic cells. Mol Ther (2005) 12(6):1157-1167.
56. Braun SE, Johnson RP: Setting the stage for bench-to-bedside movement of anti-HIV RNA inhibitors-gene therapy for AIDS in macaques. Front Biosci (2006) 11:838-851.
57. van Griensven J, De Clercq E, Debyser Z: Hematopoietic stem cell-based gene therapy against HIV infection: Promises and caveats. AIDS Rev (2005) 7(1):44-55.
58. Haviernik P, Bunting KD: Safety concerns related to hematopoietic stem cell gene transfer using retroviral vectors. Curr Gene Ther (2004) 4(3):263-276.
59. Sioud M, Sorensen DR: Cationic liposome-mediated delivery of siRNAs in adult mice. Biochem Biophys Res Commun (2003) 312(4):1220-1225.
60. Boden D, Pusch O, Lee F, Tucker L, Ramratnam B: Human immunodeficiency virus type 1 escape from RNA interference. J Virol (2003) 77(21):11531-11535.
61. Das AT, Brummelkamp TR, Westerhout EM, Vink M, Madiredjo M, Bernards R, Berkhout B: Human immunodeficiency virus type 1 escapes from RNA interference-mediated inhibition. J Virol (2004) 78(5):2601-2605.
62. Westerhout EM, Ooms M, Vink M, Das AT, Berkhout B: HIV-1 can escape from RNA interference by evolving an alternative structure in its RNA genome. Nucleic Acids Res (2005) 33(2):796-804.
63. Leonard JN, Schaffer DV: Computational design of antiviral RNA interference strategies that resist human immunodeficiency virus escape. J Virol (2005) 79(3):1645-1654.
64. Boden D, Pusch O, Silbermann R, Lee F, Tucker L, Ramratnam B: Enhanced gene silencing of HIV-1 specific siRNA using microRNA designed hairpins. Nucleic Acids Res (2004) 32(3):1154-1158.
65. Bennasser Y, Le SY, Yeung ML, Jeang KT: HIV-1 encoded candidate micro-RNAs and their cellular targets. Retrovirology (2004) 1(1):43.
66. Hariharan M, Scaria V, Pillal B, Brahmachari SK: Targets for human encoded microRNAs in HIV genes. Biochem Biophys Res Commun (2005) 337(4):1214-1218.
67. Omoto S, Fujii YR: Regulation of human immunodeficiency virus 1 transcription by Nef microRNA. J Gen Virol (2005) 86(3):751-755.
68. Dave RS, Pomerantz RJ: Antiviral effects of human immunodeficiency virus type 1-specific small interfering RNAs against targets conserved in select neurotropic viral strains. J Virol (2004) 78(24):13687-13696.
69. Puerta-Fernandez E, Barroso-del Jesus A, Romero-Lopez C, Tapia N, Martinez MA, Berzal-Herranz A: Inhibition of HIV-1 replication by RNA targeted against the LTR region. Aids (2005) 19(9):863-870.